Competitive Fitness Assays Indicate that the E138A Substitution in HIV-1 Reverse Transcriptase Decreases In Vitro Susceptibility to Emtricitabine

Por Sluis-Cremer, Nicolas, Huber, Kelly D., Brumme, Chanson J., Harrigan, P. Richard
Publicado em 2014

Lack of a significant impact of Gag-Protease-mediated HIV-1 replication capacity on clinical parameters in treatment-naive Japanese individuals

Por Sakai, Keiko, Chikata, Takayuki, Brumme, Zabrina L., Brumme, Chanson J., Gatanag, Hiroyuki, Oka, Shinichi, Takiguchi, Masafumi
Publicado no Retrovirology (2015)

Erratum to: Lack of a significant impact of Gag-Protease-mediated HIV-1 replication capacity on clinical parameters in treatment-naive Japanese individuals

Por Sakai, Keiko, Chikata, Takayuki, Brumme, Zabrina L., Brumme, Chanson J., Gatanaga, Hiroyuki, Oka, Shinichi, Takiguchi, Masafumi
Publicado no Retrovirology (2015)

Replication Fitness of Multiple Nonnucleoside Reverse Transcriptase-Resistant HIV-1 Variants in the Presence of Etravirine Measured by 454 Deep Sequencing

Por Brumme, Chanson J., Huber, Kelly D., Dong, Winnie, Poon, Art F. Y., Harrigan, P. Richard, Sluis-Cremer, Nicolas
Publicado em 2013

Sociodemographic correlates of HIV drug resistance and access to drug resistance testing in British Columbia, Canada

Por Rocheleau, Genevieve, Franco-Villalobos, Conrado, Oliveira, Natalia, Brumme, Zabrina L., Rusch, Melanie, Shoveller, Jeannie, Brumme, Chanson J., Harrigan, P. Richard
Publicado no PLoS One (2017)

Technical and Regulatory Shortcomings of the TaqMan Version 1 HIV Viral Load Assay

Por Brumme, Chanson J., Swenson, Luke C., Wynhoven, Brian, Yip, Benita, Skinner, Stuart, Lima, Viviane Dias, Montaner, Julio S. G., Harrigan, P. Richard
Publicado em 2012

The Relationship Between Resistance and Adherence in Drug-Naive Individuals Initiating HAART Is Specific to Individual Drug Classes

Por Tam, Lily W. Y., Chui, Celia K. S., Brumme, Chanson J., Bangsberg, David R., Montaner, Julio S. G., Hogg, Robert S., Harrigan, P. Richard
Publicado em 2008

HIV VprR77Q mutation does not influence clinical response of individuals initiating Highly Active Antiretroviral Therapy

Por Chui, Celia, Cheung, Peter K., Brumme, Chanson J., Mo, Theresa, Brumme, Zabrina L., Montaner, Julio S.G., Badley, Andrew D., Harrigan, P. Richard
Publicado em 2006

Limited Evolution of Inferred HIV-1 Tropism while Viremia Is Undetectable during Standard HAART Therapy

Por Lee, Guinevere Q., Dong, Winnie, Mo, Theresa, Knapp, David J. H. F., Brumme, Chanson J., Woods, Conan K., Kanters, Steve, Yip, Benita, Harrigan, P. Richard
Publicado em 2014

The Impact of Clinical, Demographic and Risk Factors on Rates of HIV Transmission: A Population-based Phylogenetic Analysis in British Columbia, Canada

Por Poon, Art F. Y., Joy, Jeffrey B., Woods, Conan K., Shurgold, Susan, Colley, Guillaume, Brumme, Chanson J., Hogg, Robert S., Montaner, Julio S. G., Harrigan, P. Richard
Publicado no J Infect Dis (2015)

Trends in plasma HIV-RNA suppression and antiretroviral resistance in British Columbia, 1997-2010

Por CESCON, Angela, KANTERS, Steve, BRUMME, Chanson J, LEPIK, Katherine J, FORREST, Jamie I, HULL, Mark, SAMJI, Hasina, NOSYK, Bohdan, HARRIGAN, P Richard, HOGG, Robert S, MONTANER, Julio SG
Publicado no J Acquir Immune Defic Syndr (2014)

Frequent Cross-Resistance to Dapivirine in HIV-1 Subtype C-Infected Individuals after First-Line Antiretroviral Therapy Failure in South Africa

Por Penrose, Kerri J., Wallis, Carole L., Brumme, Chanson J., Hamanishi, Kristen A., Gordon, Kelley C., Viana, Raquel V., Harrigan, P. Richard, Mellors, John W., Parikh, Urvi M.
Publicado no Antimicrob Agents Chemother (2017)

HLA-Associated Alterations in Replication Capacity of Chimeric NL4-3 Viruses Carrying gag-protease from Elite Controllers of Human Immunodeficiency Virus Type 1

Por Miura, Toshiyuki, Brockman, Mark A., Brumme, Zabrina L., Brumme, Chanson J., Pereyra, Florencia, Trocha, Alicja, Block, Brian L., Schneidewind, Arne, Allen, Todd M., Heckerman, David, Walker, Bruce D.
Publicado em 2009

HLA-Associated Viral Mutations Are Common in Human Immunodeficiency Virus Type 1 Elite Controllers

Por Miura, Toshiyuki, Brumme, Chanson J., Brockman, Mark A., Brumme, Zabrina L., Pereyra, Florencia, Block, Brian L., Trocha, Alicja, John, Mina, Mallal, Simon, Harrigan, P. Richard, Walker, Bruce D.
Publicado em 2009

HLA-Associated Viral Mutations Are Common in Human Immunodeficiency Virus Type 1 Elite Controllers

Por Miura, Toshiyuki, Brumme, Chanson J., Brockman, Mark A., Brumme, Zabrina L., Pereyra, Florencia, Block, Brian L., Trocha, Alicja, John, Mina, Mallal, Simon, Harrigan, P. Richard, Walker, Bruce D.
Publicado em 2010

Characteristics and Outcomes of Initial Virologic Suppressors during Analytic Treatment Interruption in a Therapeutic HIV-1 gag Vaccine Trial

Por Li, Jonathan Z., Brumme, Chanson J., Lederman, Michael M., Brumme, Zabrina L., Wang, Hongying, Spritzler, John, Carrington, Mary, Medvik, Kathleen, Walker, Bruce D., Schooley, Robert T., Kuritzkes, Daniel R.
Publicado em 2012

Automating HIV Drug Resistance Genotyping with RECall, a Freely Accessible Sequence Analysis Tool

Por Woods, Conan K., Brumme, Chanson J., Liu, Tommy F., Chui, Celia K. S., Chu, Anna L., Wynhoven, Brian, Hall, Tom A., Trevino, Christina, Shafer, Robert W., Harrigan, P. Richard
Publicado em 2012

Frequent cross-resistance to rilpivirine among subtype C HIV-1 from first-line antiretroviral therapy failures in South Africa

Por Penrose, Kerri J, Brumme, Chanson J, Scoulos-Hanson, Maritsa, Hamanishi, Kristen, Gordon, Kelley, Viana, Raquel V, Wallis, Carole L, Harrigan, P Richard, Mellors, John W, Parikh, Urvi M
Publicado no Antivir Chem Chemother (2018)

Antigen Load and Viral Sequence Diversification Determine the Functional Profile of HIV-1–Specific CD8(+) T Cells

Por Streeck, Hendrik, Brumme, Zabrina L, Anastario, Michael, Cohen, Kristin W, Jolin, Jonathan S, Meier, Angela, Brumme, Chanson J, Rosenberg, Eric S, Alter, Galit, Allen, Todd M, Walker, Bruce D, Altfeld, Marcus
Publicado em 2008

Factors Associated With Viral Rebound in HIV-1-Infected Individuals Enrolled in a Therapeutic HIV-1 gag Vaccine Trial

Por Li, Jonathan Z., Brumme, Zabrina L., Brumme, Chanson J., Wang, Hongying, Spritzler, John, Robertson, Michael N., Lederman, Michael M., Carrington, Mary, Walker, Bruce D., Schooley, Robert T., Kuritzkes, Daniel R.
Publicado em 2011